Deregulation of the Akt Pathway in Human Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|8|1|27-36

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.8, Iss.1, 2008-02, pp. : 27-36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The PKB/AKT Pathway in Cancer

By  

Current Pharmaceutical Design, Vol. 16, Iss. 1, 2010-01 ,pp. : 34-44

Bentham Science Publishers

Access to resources Recommend Favorite

Advances of AKT Pathway in Human Oncogenesis and as a Target for Anti-Cancer Drug Discovery

By  

Current Cancer Drug Targets, Vol. 8, Iss. 1, 2008-02 ,pp. : 2-6

Bentham Science Publishers

Access to resources Recommend Favorite

Diverse Mechanisms of AKT Pathway Activation in Human Malignancy

By  

Current Cancer Drug Targets, Vol. 13, Iss. 3, 2013-03 ,pp. : 234-244

Bentham Science Publishers

Access to resources Recommend Favorite

The Akt Pathway: Molecular Targets for Anti-Cancer Drug Development

By  

Current Cancer Drug Targets, Vol. 4, Iss. 3, 2004-05 ,pp. : 235-256

Bentham Science Publishers

Access to resources Recommend Favorite

The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications

By  

Current Cancer Drug Targets, Vol. 8, Iss. 3, 2008-05 ,pp. : 187-198

Bentham Science Publishers

Access to resources Recommend Favorite